|
|
|
|
Vol. 13, Issue 11, 3955-3966, November 2002

and
*Department of Biochemistry and Molecular Biology, Pennsylvania
State University, University Park, Pennsylvania 16802; and
Institute of Microbiology, ETH Zürich,
CH-8092 Zürich, Switzerland
| |
ABSTRACT |
|---|
|
|
|---|
Membrane transporter proteins are essential for the maintenance of cellular ion homeostasis. In the secretory pathway, the P-type ATPase family of transporters is found in every compartment and the plasma membrane. Here, we report the identification of COD1/SPF1 (control of HMG-CoA reductase degradation/SPF1) through genetic strategies intended to uncover genes involved in protein maturation and endoplasmic reticulum (ER)-associated degradation (ERAD), a quality control pathway that rids misfolded proteins. Cod1p is a putative ER P-type ATPase whose expression is regulated by the unfolded protein response, a stress-inducible pathway used to monitor and maintain ER homeostasis. COD1 mutants activate the unfolded protein response and are defective in a variety of functions apart from ERAD, which further support a homeostatic role. COD1 mutants display phenotypes similar to strains lacking Pmr1p, a Ca2+/Mn2+ pump that resides in the medial-Golgi. Because of its localization, the previously reported role of PMR1 in ERAD was somewhat enigmatic. A clue to their respective roles came from observations that the two genes are not generally required for ERAD. We show that the specificity is rooted in a requirement for both genes in protein-linked oligosaccharide trimming, a requisite ER modification in the degradation of some misfolded glycoproteins. Furthermore, Cod1p, like Pmr1p, is also needed for the outer chain modification of carbohydrates in the Golgi apparatus despite its ER localization. In strains deleted of both genes, these activities are nearly abolished. The presence of either protein alone, however, can support partial function for both compartments. Taken together, our results reveal an interdependent relationship between two P-type ATPases to maintain homeostasis of the organelles where they reside.
| |
INTRODUCTION |
|---|
|
|
|---|
During biosynthesis, nascent secretory proteins
first pass the membranes of the endoplasmic reticulum (ER) through a
proteinaceous pore called the translocon (Johnson and van Waes, 1999
).
In the lumen, ER chaperones and folding catalysts assist their folding and assembly. Because these factors are found only in the ER, the
folding state of proteins is monitored to assure that only properly
folded proteins traffic to their sites of function. This mechanism,
termed "ER quality control," also functions to select irreversibly
damaged proteins for degradation. In this mode, misfolded proteins are
exported back to the cytosol, presumably through the translocon, where
they are ubiquitinated and degraded by the 26S proteasome (for review,
see Brodsky and McCracken, 1999
; Ellgaard and Helenius, 2001
). Other
than the terminal step, termed ER-associated degradation (ERAD), the
mechanisms governing ER quality control remain poorly understood.
Two pioneering studies used genetic methodologies to unravel the
mechanisms underlying the degradation of proteins in the ER. One used
the direct approach of screening for mutants defective in the
degradation of two model misfolded soluble proteins: mutant carboxypeptidase Y (CPY*; Wolf and Fink, 1975
) and mutant proteinase A
(PrA*; Finger et al., 1993
; Knop et al., 1996
).
The mutant strains, termed der (degradation in
the endoplasmic reticulum), uncovered several
genes of the ubiquitin/proteasomal degradation pathway that provided
compelling evidence that misfolded proteins in the ER lumen are
exported to the cytosol for degradation. One gene, DER5, did
not fall into this category. Instead, DER5 was allelic to
PMR1. PMR1 encodes a
Ca2+/Mn2+ ion pump of the
P-type ATPase family (Durr et al., 1998
; Strayle et
al., 1999
). It was a surprising discovery because Pmr1p is a
Golgi-localized enzyme without a known equivalent in the ER of
Saccharomyces cerevisiae (Antebi and Fink, 1992
; Sorin
et al., 1997
). The requirement of PMR1 for ERAD
is likely due to its role in maintaining normal
Ca2+ levels in the ER (Durr et al.,
1998
). Pmr1p is also needed for Golgi-specific functions dependent on
divalent cations such as protein outer-chain glycosylation (Rudolph
et al., 1989
; Durr et al., 1998
).
The second study sought to understand the regulation of
hydroxymethylglutaryl-CoA reductase. In S. cerevisiae,
two isoenzymes, Hydroxymethylglutaryl-CoA reductase (Hmg)1p
and Hmg2p, contribute to the HMG-CoA reductase activity resident in the
ER membrane and play a key role in the biosynthesis of sterols and
isoprenoids (for review, see Hampton, 1998
). Whereas the Hmg1 protein
is responsible for basal constitutive activity, the Hmg2p activity is
subject to regulatory processes in part by degradation in response to feedback signals from the mevalonate pathway. Combining genetic and
biochemical approaches, Hampton and coworkers (1994)
demonstrated that
Hmg2p degradation uses core components of the ERAD pathway (Hampton and
Rine, 1994
; Hampton et al., 1996
; Hampton, 1998
). For
example, the HRD1/DER3 gene, encoding an E3 ubiquitin
ligase, is required for degrading misfolded proteins and Hmg2p (Bays
et al., 2001
). Thus, ERAD is used for ER quality control and
as a means to regulate the activity of Hmg2p. To investigate the
signaling mechanism, mutants were isolated that allowed the
constitutive degradation of Hmg2p under normally stabilizing conditions
of reduced feedback signals (Cronin et al., 2000
). These
were designated cod (control of HMG-CoA reductase
degradation) and fell into a single complementation group,
cod1. Cloning of COD1 revealed its identity as
SPF1 (Cronin et al., 2000
). SPF1 was
previously identified to confer salt mediated killer toxin
(SMKT) sensitivity, but the mechanism of action is unknown.
Interestingly, COD1/SPF1 encodes a putative P-type ATPase of
a class distinct from PMR1 (Suzuki and Shimma, 1999
).
Nevertheless, phenotypic analysis of COD1/SPF1 mutants
suggested a possible role in Ca2+ homeostasis
(Cronin et al., 2000
, 2002
). Together, the two studies established roles for P-type ATPases in ERAD, but in seemingly different ways.
ERAD activity is regulated in part by the UPR (unfolded protein
response) (Casagrande et al., 2000
; Friedlander et
al., 2000
; Ng et al., 2000
; Travers et al.,
2000
). The UPR is a signal transduction pathway between the ER and
nucleus used by the cell to monitor and respond to the changing needs
of the early secretory pathway (for review, see Patil and Walter, 2001
;
Spear and Ng, 2001
). During ER disequilibrium, an array of target genes
is transcriptionally activated to restore homeostasis (Travers et
al., 2000
). To better understand the physiological role of the
UPR, we previously performed a genetic screen to identify functions
physiologically linked to the pathway (Ng et al., 2000
).
Mutants obtained from this study, designated per (protein
processing in the ER), lead to the constitutive activation of the UPR
that, in turn, is required for their viability. A variety of functions
involved in secretory protein biogenesis and ER quality control were
revealed by this approach. One mutant, per9-1, is defective
in the degradation of CPY*. Here, we report the identity of the
PER9 gene as identical to COD1/SPF1. We show that
Cod1p is an ER-localized protein that functions together with Pmr1p to
maintain glycoprotein processing activities in protein biosynthesis and
ER quality control. Null mutants of either gene alone partially disrupt
specific functions of both the ER and Golgi, irrespective of their
primary sites of residence. Of cation-dependent functions, a cod1
pmr1 double mutation nearly abolishes activity, suggesting that
each protein can partially compensate for the loss of the other. Taken
together, our data support a model of two P-type ATPases, one in the ER
and another in the Golgi, working together to maintain homeostasis in
the two organelles.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Plasmids Used in This Study
pSM2 is an expression vector with a hemagglutinin (HA)
epitope-tagged version of COD1. To construct pSM2, the
COD1 gene was first subcloned into SpeI and
NotI (blunt by T4 DNAP) of pRS315 (Sikorski and Heiter,
1989
) as a 4580-base pair SspI/SpeI fragment to
generate the complementing clone pSM1. A C-terminal HA-epitope tag was
introduced in 3 steps: Purification of a
SacI/HpaI fragment from pSM1 containing the COD1
promoter and amino-proximal coding sequences; amplification of the 3' 1 kb of COD1 coding sequences by high-fidelity polymerase
chain reaction (PCR) using the primers S1
(5'-GCACACTTATTCCCACCTGGTCC-3') S2
(5'-CATAAAAGCCATGGCTTTAGAGGCAATCTT-3') followed by digestion with
NcoI; and purification of the vector pDN413 bearing a single
HA-epitope tag followed the ACT1 terminator in pRS315
cleaved with SacI and NcoI. pSM2 was created by
ligation of these three fragments.
pSM6 is the same as pSM2 except that HA-epitope taggedCOD1
was subcloned into pRS425 vector. The construction of pDN431
(HA-epitope tagged CPY*) was described previously (Ng et
al., 2000
). pSM1346 was a gift from S. Michaelis (Johns Hopkins
University, Baltimore, MD; Loayza et al., 1998
).
pSM5 contained the cod1::HIS3 knockout construct.
Upstream sequences (500 base pairs) of the COD1 open reading
frame were amplified by PCR using T7 and S3 primers (S3:
5'-GGGTTACCGATTCCTATGT TTC-3') and pSM1 as template. Downstream
sequences (447 base pairs) were amplified using T3 and S4 primers (S4:
5'-GGGTAAATCTTTTATGTAAGTAC-3'). The fragments were digested with
SacI and SpeI, respectively, and were inserted
into pBS SKII(+). Ligation of the two fragments created an internal
SmaI site. The HIS3 gene from pRS303 (Sikorski and Heiter, 1989
) was inserted into the SmaI site to
generate the plasmid pSM5. To generate a COD1 null strain,
pSM5 was digested with SacI and SpeI, and the
fragments were transformed into W303 diploid cells. Tetrad dissection
yielded four viable spores per tetrad with histidine prototrophs
segregating 2:2 on replica plates (our unpublished data).
Integration of HIS3 into the COD1 locus was
confirmed by PCR analysis of genomic DNA.
Cloning of the PER9 Gene
DNY507 cells were transformed with pDN388 (LEU2,
IRE1, and ADE3) to replace pDN366
(URA3, IRE1, and ADE3) by plasmid
shuffle (Ng et al., 2000
). The resulting strain was
transformed with a centromere-based genomic library (Lagosky et
al., 1987
). Approximately 10,000 transformants were grown on
synthetic complete (SC) media containing low adenine concentration (6 µg/ml) and lacking uracil, and were screened for the reversal of the
red, nonsectoring phenotype. Five sectoring colonies were picked and
streaked onto nonselective media to drop the reporter plasmid pDN388.
The plasmid clones were recovered from each strain and restriction
analysis was performed to estimate the length of each insert. The
flanking regions of the shortest clone, p82-R2, were sequenced to
reveal a 10,913-base pair fragment from chromosome V. The insert
contained four intact open reading frames (COD1/SPF1,
ECM1, BUD16, and YEL028W). Digestion of p82-R2
with ClaI followed by religation generates a plasmid (p82-R2
Cla) containing COD1/SPF1 as the only intact open
reading frame. p82-R2
Cla was found to complement all mutant
phenotypes of per9-1 and the cod1 null strain.
Cell Labeling and Immunoprecipitation
Typically, 2 A600 OD units of
log phase cells were pelleted and resuspended in 1.0 ml of SC media
lacking methionine and cysteine. After 30 min of incubation at the
appropriate temperature, cells were labeled with 480 µCi of
Tran35S-label (ICN Biomedicals, Irvine, CA). A
chase was initiated by adding cold methionine/cysteine to a final
concentration of 2 mM. The chase was initiated 30 s before the end
of the pulse to exhaust intracellular pools of unincorporated label.
Labeling/chase was terminated by the addition of trichloroacetic acid
to 10%. Preparation of cell lysates, immunoprecipitation procedures,
gel electrophoresis, and quantification of immunoprecipitated proteins were performed as described previously (Ng et al., 2000
)
Indirect Immunofluorescence
Cells were grown in appropriate SC media to an
OD600 of 0.5-0.9 and were treated with 2.5 µg/ml tunicamycin for 60 min to induce the UPR. Formaldehyde (EM
grade; Polysciences, Inc., Warrington, PA) was then added directly to
the media to 3.7% at 30°C for 1 h. After fixation, cells were
collected by centrifugation and were washed with 5 ml 0.1 M potassium
phosphate buffer (pH 7.5). Cell walls were disrupted by incubation in
1.0 mg/ml zymolyase 20T (ICN Biomedicals, Aurora, OH) in 0.1 M
potassium phosphate, pH 7.5, and 0.1% 2-mercaptoethanol for 30 min at
30°C. Spheroplasts were washed once with phosphate-buffered saline
(PBS) and were resuspended. Thirty microliters of cell suspension was
applied to each well of a poly-L-lysine-coated slide for 1 min and were washed three times with PBS. Slides were immersed in
methanol for 5 min followed by immersion in acetone for 30 s at
20°C and were allowed to air dry. Subsequent steps were performed
at room temperature. Thirty microliters of PBS block (3% bovine serum albumin in PBS) was added to each well and was incubated for 30 min.
Primary antibodies
-HA or
-Kar2p applied were used at 1:1000 or
1:5000 dilutions in PBS block, respectively, for 1 h. Wells were
washed three to five times with PBS block. Thirty microliters of
secondary antibodies (Alexa Fluor 488 goat
-mouse or
-rabbit and
Alexa Fluor 546 goat
-mouse or
-rabbit; Molecular Probes, Sunnyvale, CA) was added to wells and incubated for 45 min in the dark.
Wells were washed five to seven times with PBS block and two times with
PBS. Each well was sealed with 5 µl of mounting medium (PBS, 90%
glycerol, and 0.025 µg/ml 4,6-diamidino-2-phenylindole) and a glass
coverslip. Samples were viewed on a Zeiss Axioplan epifluorescence
microscope (Carl Zeiss, Thornwood, NY). Images were collected using a
Spot 2 cooled charged-coupled device camera (Diagnostic Instruments,
Sterling Heights, MI) and were archived using Adobe Photoshop 4.0 (Adobe Systems, Mountain View, CA).
Labeling, Extraction, and Analysis of N-linked Oligosaccharides
Cells were grown in yeast extract/peptone/dextrose (YPD) at
30°C to midlog phase. Cells (4 × 108)
were harvested, washed once with low glucose medium (YP with 0.1%
glucose [YP0.1D]), and resuspended in 200 µl of YP0.1D.
Oligosaccharide labeling was started by the addition of 50 µl of
YP0.1D containing 95 µCi of
2-[3H]D-mannose (21 Ci/mmol;
Moravek Biochemicals, Brea, CA). After incubation for 12 min at 30°C,
lipid-linked oligosaccharides were extracted as described previously
(Zufferey et al., 1995
). The pellet containing glycoprotein
was dried, resuspended in 200 µl of 0.75% SDS and 2%
2-mercaptoethanol, and denatured for 10 min at 100°C. N-glycans were
released by enzymatic hydrolysis for 14 h at 37°C in 300 µl of
0.5% SDS, 1% NP40, 50 mM sodium phosphate, pH 7.5, 1.33%
2-mercaptoethanol, and 2 U of N-glycosidase F (Roche Molecular
Biochemicals, Indianapolis, IN). Cell debris was removed by ethanol
precipitation. The N-linked oligosaccharides were analyzed by high-performance liquid chromatography as previously described (Zufferey et al., 1995
). A mixture of radiolabeled
oligosaccharides of known structure served as standard.
| |
RESULTS |
|---|
|
|
|---|
The PER9 Gene Encodes a Putative P-type ATPase Localized in the ER
We previously reported that the unfolded protein response
regulates multiple functions of the ER to maintain homeostasis (Ng et al., 2000
). In that study, a genetic strategy uncovered
mutants (designated per) defective for a variety of ER
functions, including ERAD. To better understand ER quality control
mechanisms, we focused our efforts to clone the complementing genes of
ERAD-defective per mutants. Among these, PER8 and
PER16 were identified as the ERAD-related genes
SON1/RPN4 and UBC7, respectively (Biederer et al., 1997
; Mannhaupt et al., 1999
). One
mutant, per9-1, was not complemented by known ERAD genes in
our collection, suggesting that the PER9 gene might be
novel. Using a colony color sectoring assay, several complementing
clones were isolated from a centromere-based genomic library (see
"Materials and Methods"). By sequencing both ends of the shortest
clone, we determined that PER9 was contained within a
10,913-base pair fragment from chromosome V. Of four intact open
reading frames found within the insert, deletion mapping showed that
PER9 is identical to the COD1/SPF1 gene
(hereafter referred as COD1 for simplicity; Suzuki and
Shimma, 1999
; Cronin et al., 2000
). Together, these data
suggest that COD1 is required for efficient degradation of
misfolded proteins in addition to its previously defined roles in
killer toxin sensitivity and regulation of HMGR stability.
To facilitate analysis of the Cod1 protein, an HA-epitope tagged
version of the gene controlled by the native promoter was constructed
(Cod1pHA, see "Materials and Methods" for
details). The tagged version is functional as it complements every
mutant phenotype examined (our unpublished data). We next sought
to determine the site of Cod1p function because Pmr1p, another P-type
ATPase needed for ERAD, is a resident of the Golgi apparatus. Indirect immunofluorescence was performed to localize
Cod1pHA. As shown in Figure
1, Cod1pHA staining
is prominent in regions underlying the plasma membrane and within the
nuclear envelope. These features are distinct from the Golgi apparatus,
which appears punctate in budding yeast (Rossanese et al.,
1999
). Instead, the pattern is characteristic of the ER. This assertion
was confirmed by perfect coincident staining with BiP, a
well-established ER marker (Figure 1, compare a and b). In addition,
induction of Cod1p expression by tunicamycin does not alter its
localization under cellular stress (Figure 1, d and e). These data show
that Cod1p is primarily localized in the ER and are in agreement with a
recent report by Hampton and colleagues (Cronin et al.,
2002
)
|
|
The COD1 Gene Is Regulated by the UPR Signaling Pathway
Among P-type ATPases with established functions, most couple ATP
hydrolysis to the transport of ions across membranes (Catty et
al., 1997
). These proteins are present in every compartment of the
secretory pathway and function primarily to maintain transmembrane ion
gradients. The per9-1 mutant was isolated on the basis of a
synthetic lethal interaction with IRE1, a key component of
UPR signaling pathway. In per9-1 cells, the UPR is
constitutively activated, indicating that the loss of COD1
activity causes ER disequilibrium (Ng et al., 2000
). This
was not surprising given the established cellular roles of P-type
ATPases. Because of its physiological link to the UPR, we wondered
whether the pathway directly regulates COD1. For this, we
measured the synthesis of COD1 message and protein after
treatment with the glycosylation inhibitor tunicamycin, a potent
inducer of the UPR. As shown in Figure
2A, COD1 mRNA is elevated
1.8-fold after 60 min of treatment. This is in agreement with data
obtained by whole genome expression analysis (Travers et
al., 2000
). The induction is UPR specific because no change is
observed under identical conditions in the UPR-deficient strain
hac1 (Figure 2A, lanes 3 and 4). To confirm that an
increase in message level results in an increase in Cod1 protein
synthesis, the translation rate was measured. As shown in Figure 2B,
Cod1pHA synthesis is elevated 3.3- and 3.8-fold after 60 and 120 min of tunicamycin treatment, respectively. Under stress, although Cod1p levels are elevated, it remains localized in the
ER (Figure 1, d and e). These data show that COD1 is part of
the UPR regulatory program for maintaining ER homeostasis. By contrast,
PMR1 transcript levels do not change in response to ER
stress, and a pmr1 null mutant does not exhibit synthetic interactions with IRE1 (Durr et al., 1998
and our
unpublished data).
|
The Requirement of COD1 and PMR1 in ERAD Is Substrate Specific
Because Cod1p and Pmr1p are localized to distinct compartments, we
wished to understand their respective roles in ERAD. We constructed
strains deleted of the COD1 and PMR1 genes to
compare the effects when either or both proteins are absent. We
measured the rates of CPY* degradation by metabolic pulse-chase
analysis. As shown in Figure 3A, the
delay of CPY* degradation was similar in the cod1 and
pmr1 single mutants. By contrast, CPY* turnover was most
compromised in the double mutant. Because the effects of the mutations
are additive, the data suggest that the two proteins function
independently in their respective compartments. The trivial explanation
that the increased severity is a consequence of a general loss of ER
function could be ruled out because translocation and core
glycosylation of proteins remained normal in the double mutant (Figure
5).
|
The requirement of COD1 and PMR1 in degrading
CPY* was somewhat puzzling because HMGR is turned over rapidly
in strains deleted of these genes (Cronin et al., 2000
). As
both proteins are substrates of ERAD, these observations could reflect
different requirements for misfolded versus folded proteins. Although
reasonable, we explored an alternative possibility. We recently
reported that at least two quality control mechanisms target substrates
for ERAD (Vashist et al., 2001
). Some substrates like CPY*
are transported to and recycled from the Golgi, whereas other mutant
proteins like Ste6-166p are retained statically in the ER. Thus, we
wondered whether the requirement for COD1 and
PMR1 in degrading misfolded proteins is substrate and/or
pathway specific. To address this question, we also measured the
turnover of Ste6-166p in the various mutant strains. Ste6-166p is a
misfolded version of Ste6p, a multispanning integral membrane protein
normally localized at the plasma membrane (Loayza et al.,
1998
). As shown in Figure 3B, Ste6-166p is degraded normally in strains
deleted of either gene. Furthermore, a cod1 pmr1 double
mutant also degraded Ste6-166p efficiently despite being growth
impaired. These data show that COD1 and PMR1 are required only for a subset of substrates, and that core functions of
the ERAD machinery are functional in the absence of these genes.
Loss of COD1 and PMR1 Alters the Trimming of N-linked Oligosaccharides
We next explored how the loss of COD1 and
PMR1 disrupts CPY* degradation and not Ste6-166p. We noticed
that the proteins differ in their glycosylation states (CPY* is
N-glycosylated at four sites, whereas Ste6-166p is nonglycosylated
[our unpublished data]). This might be important because some
ERAD substrates, including CPY*, must contain properly processed
carbohydrates for efficient degradation (Knop et al., 1996
;
Jakob et al., 1998
). Along these lines, we tested whether
the loss of COD1 or PMR1 might impair glycosylation and/or processing. To analyze the extent of
glycosylation, we examined the synthesis of endogenous glycoproteins in
the mutant strains. First, we observed that the addition of core
carbohydrates immediately after a pulse-label is normal when compared
with wild type (Figure 5, A and B, "-Endo H"). We conclude that the
core glycosylation of proteins is unimpaired in the mutant strains.
Next, we analyzed the processing of N-linked
oligosaccharides. A key enzyme in the oligosaccharide processing is ER
mannosidase I. Mannosidase I was shown to contain a coordinated
Ca2+ that is essential for its activity (Vallee
et al., 2000
). As Pmr1p and possibly Cod1p participate in
maintaining calcium homeostasis, we reasoned that the mutants might
display defects in N-glycan processing. We in vivo labeled
oligosaccharides in various yeast cells and analyzed the N-glycan
composition of the cells at steady-state level. Wild-type cells showed
mainly the trimmed
Man8GlcNAc2
N-linked oligosaccharide, as previously reported (Jakob
et al., 1998
). The
cod1 and
pmr1
single mutants contained
Man8GlcNAc2 and
Man9GlcNAc2 oligosaccharides at approximately equal quantities (Figure
4). The
cod1
pmr1 double
mutant, however, accumulated most prominently the
Man9GlcNAc2
oligosaccharide, the N-glycan that does not support degradation when
attached to CPY* (Figure 4; Knop et al., 1996
; Jakob
et al., 1998
). From these data, we conclude that
oligosaccharide processing by the Ca2+-dependent
mannosidase I is most significantly impaired in the
cod1
pmr1 double mutant; oligosaccharide trimming in
the single mutants is also affected, but to a lesser degree. The extent
of the trimming defects correlates well with their respective CPY* degradation rates (Figure 3). As ERAD is not generally disrupted in
these mutants, these data provide a biochemical basis for why CPY*
degradation is impaired, whereas Hmg2p (Cronin et al., 2000
) and Ste6-166p (Figure 3B) can be degraded efficiently.
|
Modification of Oligosaccharide Chains in the Golgi Requires the Combined Functions of COD1 and PMR1
Pmr1p helps maintain Mn2+ homeostasis needed
for Golgi enzymes that modify protein-linked oligosaccharides (Durr
et al., 1998
). As such, pmr1 mutants exhibit
defects in outer chain glycosylation that are consistent with its
localization. It was more surprising to uncover its role in
Man9GlcNAc2 to
Man8GlcNAc2 oligosaccharide trimming because this occurs exclusively in the ER. Because Cod1p is
also needed for this activity, we wondered whether this ER protein is
also needed for Golgi modification of carbohydrates. To address this
question, we compared the maturation of endogenous cargo proteins Gas1p
and CPY. The mature forms of these proteins are localized at the plasma
membrane and vacuole, respectively (Fankhauser and Conzelmann, 1991
;
Van Den Hazel et al., 1996
). During transit through the
Golgi apparatus, their carbohydrate chains are extended, and the
modifications can be observed by characteristic decreases in gel
mobility. After a 10-min pulse, CPY migrates in a polyacrylamide gel in
two forms: a faster P1 form (ER) and a slower migrating P2 form (Golgi)
(Figure 5A, lane 1, "-Endo H"). The
shift in mobility to the P2 form is reduced in the
cod1
and
pmr1 single mutants and is abolished in the double
mutant (Figure 5A, lanes 2 through 4, "-Endo H"). The alterations reflect defects in Golgi carbohydrate processing because mature CPY
("mCPY," proteolytically processed in the vacuole) generated after
the chase maintain the mobility differences (Figure 5A, "-Endo H,"
lanes 5 through 8), and removal of N-linked sugars eliminates these differences (Figure 5A, "+Endo H"). A similar pattern emerged for the plasma membrane protein Gas1p. Gas1p differs from CPY as it is modified by both N- and
O-linked sugars that are extended in the Golgi. After a
10-min pulse, the Gas1p ER forms from each strain migrate identically,
indicating that O-mannosylation and core N-linked
oligosaccharide addition are unaffected (Figure 5B, lanes 1 through 4, "-Endo H"). Although a small amount of the Golgi-modified forms was
apparent after the pulse, a 30-min chase was applied to complete the
processing. In each case, Gas1p was processed into a slower migrating
Golgi form. However, Gas1p is modified only partially in
cod1, even less efficiently in
pmr1, and is
most compromised in the
cod1
pmr1 double mutant (Figure
5B, lanes 5 through 8, "-Endo H"). The defect is not exclusive to
N-linked sugars because Endo H digestion does not completely eliminate the mobility differences, indicating a defect in the extension of O-mannosylated residues (Figure 5B, lanes 5 through 8, "+Endo H").
|
Because a significant fraction of the protein-linked oligosaccharides
are of the untrimmed
Man9GlcNAc2 form in each
mutant, we wondered whether the defects in outer chain glycosylation
are simply due to this species being a poor substrate for
Golgi-modifying enzymes. For this question, we analyzed the processing
of CPY and Gas1p in a strain deleted of the MNS1 gene
(coding for the ER mannosidase). Trimming of
Man9GlcNAc2 to
Man8GlcNAc2
oligosaccharides in the ER is abolished in this strain (Figure 5C, lane
P; visualized by slight changes of electrophoretic mobility of CPY and
Gas1p) (Puccia et al., 1993
). As shown in Figure 5C, both
proteins are processed in the Golgi, indistinguishably from wild type,
confirming that Man8GlcNAc2
(wild-type) and Man9GlcNAc2
(
mns1) carbohydrates can be extended normally in the
Golgi (Puccia et al., 1993
).
PMR1 and COD1 Are Required for the Normal Transport of Cargo Proteins
A strain lacking PMR1 was previously observed as
defective in the trafficking of CPY and chitinase, suggesting that
proper Ca2+ and Mn2+ levels
in the ER and/or Golgi are important for vesicular transport (Durr
et al., 1998
). If Cod1p works with Pmr1p to maintain luminal homeostasis, we expect to observe similar trafficking defects in
cod1 cells that are exacerbated in the double mutant.
Metabolic pulse-chase experiments were performed to monitor the
transport of two endogenous cargo proteins, Gas1p and CPY. As shown in
Figure 6A, processing of Gas1p to the
Golgi form was delayed in
cod1 cells
(t1/2 18 min) and, to a lesser extent, in
pmr1 cells (t1/2 13 min) when
compared with wild type (t1/2 10 min). These data are consistent with an ER-to-Golgi transport defect. For the
cod1
pmr1 mutant, the two Gas1p glycoforms were not
resolvable, therefore we were unable to quantify the extent of the
transport defect (Figure 6A, bottom). However, it was possible to
analyze the trafficking of CPY in this strain. Protein trafficking from
the ER to vacuole was monitored through the processing of proCPY
(Figure 6B, "P1 and P2") to the mature vacuolar form (Figure 6B,
"mCPY"). The maturation of CPY was found most disrupted in the
cod1
pmr1 double mutant (t1/2 26 min) and to a lesser extent in the
cod1 and
pmr1 mutants (t1/2, 15 and 18 min,
respectively) as compared with wild type (t1/2 9 min). The requirement for Cod1p and Pmr1p in the vesicular transport of
cargo proteins provides an additional line of evidence of their
interdependence in maintaining organelle homeostasis.
|
| |
DISCUSSION |
|---|
|
|
|---|
Through our efforts to understand the physiology of the unfolded
protein response, a variety of functions were uncovered that are
monitored and/or regulated by the pathway. Using a genetic approach, we
identified genes affecting N- and O-linked
glycosylation, protein translocation, folding,
glycosylphosphatidylinositol addition, quality control, and
ERAD (Ng et al., 2000
and our unpublished data). Together,
these account for most requisite functions used for ER protein
maturation. The discovery of COD1 expanded the breadth of
our analysis because it likely functions to maintain ion homeostasis of
the luminal environment.
Cod1p belongs to the P-type ATPase family of enzymes that primarily
catalyze the ATP-dependent transport of ions across membranes (Catty
and Goffeau, 1996
). Common to all P-type ATPases is the formation of a
phosphorylated aspartyl-intermediate during the reaction cycle (Catty
et al., 1997
), a residue that was recently shown to be
important for suppressing the SMKT-resistant phenotype of
cod1/spf1 mutants (Suzuki and Shimma, 1999
). Based on
primary sequence, Cod1p has been placed in the type V subfamily of
these enzymes (Axelsen and Palmgren, 1998
). Although the molecules
transported by Cod1p are not yet conclusively determined, recent
evidence from Hampton and colleagues suggest that calcium might be
among them (Cronin et al., 2000
, 2002
). Our data showing
functions requiring luminal Mn2+ and
Ca2+ to be compromised in
cod1
cells support that view. In mammals, type IIa P-type ATPases called
sarco [endoplasmic] reticulum calcium ATPase (SERCA) pumps are
responsible for the maintenance of ER luminal
Ca2+. However, SERCA pumps are absent from a
large number of eukaryotic organisms, including fungi and plants. In
yeast, two calcium ATPases, Pmr1p and Pmc1p, were previously
identified. Pmr1p belongs to the family of type IIa P-type ATPases, but
exhibits properties that are distinct from those of the SERCA pumps.
The Golgi-localized Pmr1p was shown to also transport
Mn2+ (Durr et al., 1998
). The other
calcium P-type ATPase found in yeast is the vacuolar Pmc1p, which is
closely related to the mammalian plasma membrane P-type ATPase
(Cunningham and Fink, 1994
). The yeast vacuole accumulates >95% of
the total cell-associated calcium (Eilam et al., 1985
).
Strains lacking both calcium pumps are not viable (Cunningham and Fink,
1994
).
Due to the lack of any SERCA pumps in yeast, it was suggested that
PMR1 is responsible for maintaining the supply of calcium to
the ER. This hypothesis was supported by the observations that CPY*
degradation is inhibited in PMR1 mutants, and the expression of the rabbit SERCA1a pump can abrogate low Ca2+
and EGTA sensitivity in pmr1 null cells (Durr et
al., 1998
). In addition, the measurement of free
Ca2+ in the ER revealed a 50% decrease in
pmr1 null mutants (Strayle et al., 1999
). Taken
together, these studies demonstrate an important role for Pmr1p in
maintaining ER Ca2+ homeostasis, but did not rule
out the possibility of other transporters.
The COD1 gene was initially identified as SPF1;
mutations in this gene result in resistance to
Pichia farinosa killer toxin (Suzuki and
Shimma, 1999
). A noted phenotype of SPF1 mutants was expression of underglycosylated invertase although the precise nature
of the defect was unclear. In an independent genetic study, COD1 was discovered for its involvement in regulating the
degradation of Hmg2p (Cronin et al., 2000
). Although its
role in Hmg2p regulation is not yet understood, adjustment of
Ca2+ concentrations in the media partially
restored regulation in a COD1-deficient strain, whereas
Ca2+ depletion in the media of wild-type cultures
was disruptive. In addition, a cod1
mutant activates
calcium responsive genes and strongly increases intracellular calcium
levels when combined with a PMR1 deletion (Cronin et
al., 2002
). Taken together with our results, the data implicate a
requirement for COD1 in Ca2+
homeostasis. To identify the ion(s) transported by Cod1p, Hampton and
coworkers used a biochemical approach that took advantage of the
substrate-coupled ATPase activity of most P-type ATPases (Cronin
et al., 2002
). Surprisingly, neither
Ca2+ nor Mn2+ stimulated
the ATPase activity of purified Cod1p. Although their results do not
rule out these ions as substrates, they raised the possibility of
accessory factors or substrates of Cod1p yet to be determined.
Our study extends and integrates observations of previous studies of
the COD1 and PMR1 genes. We show that
COD1 mutants share several phenotypes with a strain deleted
of PMR1, raising the possibility that the two genes perform
similar functions even as they are localized to distinct compartments.
In ERAD, both genes are needed for the degradation of CPY*, but are
dispensable for Ste6-166p and Hmg2p. As these are all substrates of
ERAD, the seemingly contradictory observation could be explained by a
common defect in oligosaccharide processing. By analyzing
protein-linked oligosaccharides, we determined that
Man9GlcNAc2 to
Man8GlcNAc2 carbohydrate
trimming is compromised in strains lacking either or both transporters.
The enzyme responsible for this processing step, ER mannosidase I,
requires Ca2+ for activity (Vallee et
al., 2000
). As the effect on trimming is nearly identical when
either gene is lacking (Figure 4), it seems likely that loss of
COD1 compromises ER Ca2+ levels as was
shown for a pmr1 strain. As CPY* degradation requires N-glycan trimming (Knop et al., 1996
; Jakob et
al., 1998
) and neither Ste6-166p nor Hmg2p have this requirement
(Figure 3B and C.A. Jakob, unpublished data), it likely account for
most, if not all, of the ERAD phenotype. The trimming defect is most
severe in the double mutant, suggesting that Cod1p functions
independently of Pmr1p rather than as a factor that regulates Pmr1p
activity. In addition, a second-site suppression screen to identify
further genes involved in protein degradation was performed. The
screening procedure was based on the observation that the
temperature-sensitive growth phenotype of the stt3-7 allele
can be suppressed by inactivating nonessential genes involved in ERAD
(Jakob et al., 2001
). The Stt3 protein, an essential subunit
of the oligosaccharyltransferase complex, is N-glycosylated and spans
the ER membrane at least 10 to 12 times. In this genetic screen,
multiple mutant alleles of the COD1 gene were isolated (R. Szathmary and C.A. Jakob, unpublished data). The fact that inactivation
of COD1 not only reduced the degradation of a soluble
glycoprotein (CPY*; Figure 4) but also of a membrane-spanning mutant
glycoprotein (stt3-7p) indicates the importance of
Ca2+ homeostasis in efficient degradation of glycoproteins.
In the Golgi apparatus, Pmr1p is needed for correct outer chain
processing of carbohydrate chains (Durr et al., 1998
). This requirement is attributed to the maintenance of luminal
Mn2+, a cofactor of the processing enzymes.
Surprisingly, we found that COD1 mutants are similarly
defective in this function despite its ER localization (Figure 5). This
is the reciprocal relationship to PMR1 and ER carbohydrate
processing. Furthermore, cells lacking both genes are the most
compromised and are entirely ineffective in converting proCPY from the
ER P1 form to the Golgi P2 form. From these data, we conclude that
luminal homeostasis of each compartment is dependent, not only on its
own resident transporter, but also on the transporter of the other
organelle. The importance of the partnership is underscored by the
exacerbation of functional phenotypes as well as severely impaired
growth in the double mutant. Despite the extent of the defects, they
are specific because other ER functions, including the transfer of
oligosaccharides to asparagine side chains and protein import, are
unaffected even in the double mutant (Figure 5).
Despite phenotypic similarities between COD1 and
PMR1 mutants, there are important differences. We identified
COD1 through a synthetic lethality screen with
IRE1, a key component of the unfolded protein response.
Activation of the UPR is believed to alleviate disequilibrium caused by
ER stress. Loss of COD1 function leads to the constitutive
activation of the UPR (Ng et al., 2000
). This phenotype is
consistent with our data that ER functions are perturbed. We also
demonstrated that COD1 is part of the UPR program because
its expression is induced through the pathway during ER stress (Figure
2). By contrast,
pmr1
ire1 mutants are viable and
pmr1 mutants do not constitutively activate the UPR,
suggesting that critical ER functions are not as compromised as in
cod1 mutants (Durr et al., 1998
and our
unpublished data). Consistent with this view, the regulation of Hmg2p
degradation in the ER is disrupted in
cod1 strains, but
is unaffected in strains lacking PMR1 (Cronin et
al., 2000
). In addition, a recent report showed that mutants
lacking COD1 exhibit defects in membrane protein orientation, whereas a strain lacking PMR1 was unaffected
(Tipper and Harley, 2002
). Conversely, the Golgi-localized modification of carbohydrates is more compromised in
pmr1 than in a
cod1 mutant (Figure 5). These data show that although
both proteins are needed to maintain homeostasis of the ER/Golgi
membrane system, each is less dispensable for their respective organelles.
Our study reveals a functional partnership of two related but
distinctly localized proteins in maintaining the luminal homeostasis of
two organelle systems. It was previously shown that one of these
proteins, Pmr1p, is needed for ER function, although localized primarily in the Golgi (Durr et al., 1998
). The extensive
exchange of luminal contents through anterograde and retrograde
transport can explain how disequilibrium of one compartment can affect
the other. The reciprocal relationship with the ER-localized Cod1p provides another facet of this homeostatic mechanism. Although our
studies support a role of Cod1p as part of the UPR regulatory program
in maintaining the ER, future work will focus on how both genes are
coordinately regulated to maintain homeostasis in the ER/Golgi membrane system.
| |
ACKNOWLEDGMENTS |
|---|
The authors thank Drs. Gerald Fink and Reid Gilmore for strains and antibodies. We also thank Dr. M. Aebi for support and A. Toscan and R. Szathmary for technical assistance. This work was supported by the National Institutes of Health Grant GM-59171 to D.T.W.N. and by the ETH to C.A.J.
| |
FOOTNOTES |
|---|
Corresponding author. E-mail address:
dtn1{at}psu.edu.
DOI: 10.1091/mbc.02-06-0090.
| |
REFERENCES |
|---|
|
|
|---|
-mannosidase gene does not prevent outer chain synthesis in Saccharomyces cerevisiae.
Biochem. J.
290, 21-26.
1,2-mannosidase involved in N-glycan processing and endoplasmic reticulum quality control.
EMBO J.
19, 581-588[CrossRef][Medline].
1,2-mannosidase involved in N-glycan processing and endoplasmic reticulum quality control.
EMBO J.
19, 581-588.This article has been cited by other articles:
![]() |
S. Pu, K. Ronen, J. Vlasblom, J. Greenblatt, and S. J. Wodak Local coherence in genetic interaction patterns reveals prevalent functional versatility Bioinformatics, October 15, 2008; 24(20): 2376 - 2383. [Abstract] [Full Text] [PDF] |
||||
![]() |